Evidence map›Paper›PMID 37808827›Full record

ArticlebioRxiv : the preprint server for biology2023

Prolonged delays in human microbiota transmission after a controlled antibiotic perturbation.

Katherine S Xue, Sophie Jean Walton, Doran A Goldman, Maike L Morrison, Adrian J Verster, Autumn B Parrott, Feiqiao Brian Yu, Norma F Neff, Noah A Rosenberg, Benjamin D Ross and 4 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 20 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Katherine S XueDepartment of Biology, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-4094-3615
Sophie Jean WaltonDepartment of Biology, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0003-1320-1525
Doran A GoldmanDepartment of Biology, Stanford University, Stanford, CA 94305, USA.ORCID 0009-0001-7838-5209
Maike L MorrisonDepartment of Biology, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0003-0430-1401
Adrian J VersterDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth College, Hanover, NH 03755, USA.ORCID 0009-0003-5039-0780
Autumn B ParrottDepartment of Bioengineering, Stanford, CA 94305, USA.
Feiqiao Brian YuChan Zuckerberg Biohub, San Francisco, CA 94158, USA.ORCID 0000-0003-3416-3046
Norma F NeffChan Zuckerberg Biohub, San Francisco, CA 94158, USA.ORCID 0000-0001-7141-5420
Noah A RosenbergDepartment of Biology, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-1829-8664
Benjamin D RossDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth College, Hanover, NH 03755, USA.ORCID 0000-0002-8817-3138
Dmitri A PetrovDepartment of Biology, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-3664-9130
Kerwyn Casey HuangDepartment of Bioengineering, Stanford, CA 94305, USA.ORCID 0000-0002-8043-8138
Benjamin H GoodDepartment of Biology, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-7757-3347
David A RelmanDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0001-8331-1354
Chan Zuckerberg Initiative (United States) · USStanford University · USDartmouth College · USApplied BioPhysics (United States) · USVA Palo Alto Health Care System · US

Funding

Genomics of rapid adaptation in the lab and in the wildR35GM118165 · NIGMS · STANFORD UNIVERSITY · PI Dmitri Petrov · 2016 to 2026
$8.3M
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an AntibioticR01AI147023 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI RELMAN, DAVID A. · 2020 to 2024
$3.5M
Mechanisms of adaptation to interbacterial antagonism by the human gut microbiotaR35GM142685 · NIGMS · DARTMOUTH COLLEGE · PI ROSS, BENJAMIN DAVIDSON · 2021 to 2025
$2.0M
Quantitative approaches for mapping the real-time evolution of the gut microbiotaR35GM146949 · NIGMS · STANFORD UNIVERSITY · PI Benjamin H Good · 2022 to 2026
$2.0M
Household transmission of the human gut microbiota after antibiotic exposureR21AI168860 · NIAID · STANFORD UNIVERSITY · PI RELMAN, DAVID A. · 2023 to 2024
$426k
NIAID NIH HHS R01 AI147023NIAID NIH HHS R21 AI168860NIGMS NIH HHS R35 GM118165NIGMS NIH HHS R35 GM142685NIGMS NIH HHS R35 GM146949
6 · The paper itself

Abstract

Humans constantly encounter new microbes, but few become long-term residents of the adult gut microbiome. Classical theories predict that colonization is determined by the availability of open niches, but it remains unclear whether other ecological barriers limit commensal colonization in natural settings. To disentangle these effects, we used a controlled perturbation with the antibiotic ciprofloxacin to investigate the dynamics of gut microbiome transmission in 22 households of healthy, cohabiting adults. Colonization was rare in three-quarters of antibiotic-taking subjects, whose resident strains rapidly recovered in the week after antibiotics ended. In contrast, the remaining antibiotic-taking subjects exhibited lasting responses, with extensive species losses and transient expansions of potential opportunistic pathogens. These subjects experienced elevated rates of commensal colonization, but only after long delays: many new colonizers underwent sudden, correlated expansions months after the antibiotic perturbation. Furthermore, strains that had previously transmitted between cohabiting partners rarely recolonized after antibiotic disruptions, showing that colonization displays substantial historical contingency. This work demonstrates that there remain substantial ecological barriers to colonization even after major microbiome disruptions, suggesting that dispersal interactions and priority effects limit the pace of community change.

Identifiers

PMID37808827
PMCPMC10557656
OpenAlexW4387104634

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.